A diagnostic test for the detection of beta-amyloid (1-42), a biomarker used in Alzheimer's disease diagnosis and monitoring.
Manufactured by
China
CanAg Diagnostics (Fujirebio) is a global leader in in-vitro diagnostics and the world's largest manufacturer of tumor marker gold standards. The company provides detection products for most common solid tumors including gastrointestinal, squamous cell, liver, pancreatic, prostate, ovarian, skin, and lung cancers. All products are manufactured in ISO13485-certified facilities in Sweden and USA, supplying tumor marker antigens and antibodies to major international diagnostic manufacturers.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
SHENZHEN ANQUN BIOTECH CO.,LTD.
China · 11 relevant products
Chongqing Kangjuquanhong Biotechnology Co.,Ltd.
China · 4 relevant products
IBL-America
United States · 5 relevant products
Ailex Technology Group Co.,Ltd
China · 2 relevant products
Diazyme Laboratories, Inc.
United States · 5 relevant products
Athens Bioscience, Inc
United States · 1 relevant product
Fujirebio Europe
Belgium · 4 relevant products
Anhui Deepblue Medical Technology Co., Ltd.
China · 1 relevant product
Dynamiker Biotechnology (Tianjin) Co., Ltd.
China · 1 relevant product
Guangzhou Labsim Medical Diagnostics Co., Ltd.
China · 2 relevant products
43 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 94 closest product alternatives
SHENZHEN ANQUN BIOTECH CO.,LTD. · China
Enzyme-linked immunoassay (ELISA) kit for quantitative detection of human beta amyloid 1-42 in serum or plasma samples. Designed for early diagnosis and assessment of Alzheimer's disease and neurodegenerative disorders. The kit provides reliable biomarker measurement to support clinical evaluation of cognitive decline and dementia risk.
SHENZHEN ANQUN BIOTECH CO.,LTD. · China
Chemiluminescent assay kit for quantitative detection of beta amyloid 1-42 in patient samples. Designed for early diagnosis and monitoring of Alzheimer's disease and neurodegenerative disorders. Provides rapid, sensitive results using chemiluminescent immunoassay methodology for clinical laboratory use.
SHENZHEN ANQUN BIOTECH CO.,LTD. · China
A kit for in vitro quantitative detection of human beta-amyloid 1-42 (Aβ1-42) concentration in human serum. Available in specifications of 24 tests/box, 48 tests/box, and 96 tests/box. Detection methods: ELISA or chemiluminescence.
Chongqing Kangjuquanhong Biotechnology Co.,Ltd. · China
A diagnostic test kit for measuring β-amyloid protein 1-42 using magnetic microparticle chemiluminescence immunoassay method. Applied in dementia assessment.
IBL-America · United States
Solid phase sandwich ELISA for the determination of human Aβ (1-x) in EDTA-plasma, cerebrospinal fluids, serum, cell culture media, or extracts from brain tissue. This assay measures various forms of amyloid beta peptides relevant to Alzheimer's disease research. For research use only, not for use in diagnostic procedures.
Ailex Technology Group Co.,Ltd · China
An immunochromatographic reagent kit for the detection of human beta-amyloid protein in clinical samples. This diagnostic reagent is used for neurological disease assessment and research applications.
Diazyme Laboratories, Inc. · United States
Quantitative determination of Amyloid-β42 (Aβ42) concentration in EDTA plasma on chemiluminescence analyzer.
IBL-America · United States
Solid phase sandwich ELISA for the determination of human Aβ molecules that bind to anti-human Aβ (N) (82E1) mouse monoclonal antibody with two or more epitopes (oligomers, polymers with protein, etc.) in serum, EDTA-plasma, and brain tissue extract. For research use only, not for use in diagnostic procedures.
Athens Bioscience, Inc · United States
Pure native amyloid-beta for Alzheimer's disease diagnostic assay development. Serves as a reference material in neurodegenerative disorder testing.
IBL-America · United States
Monoclonal antibody targeting the N-terminal region of Amyloid Beta (Aβ) peptide, a 40 to 43 amino acid protein that is the major component of extracellular plaques in Alzheimer's disease. This antibody is used for research applications in studying Alzheimer's disease pathology and amyloid-related processes.
Fujirebio Europe · Belgium
Fully automated plasma assay for amyloid-beta 42 detection in Alzheimer's disease diagnosis. Ultra-sensitive measurement of key Alzheimer's pathology biomarker.
Diazyme Laboratories, Inc. · United States
Quantitative determination of Amyloid-β40 (Aβ40) concentration in EDTA plasma on chemiluminescence analyzer.
82 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products